StreetInsider.com News Articles

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Mon, 15 Jun 2026 08:30:00 -0400

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Thursday, June 18, 2026, beginning at 10:00 a.m. Pacific Time.

The live webcast can be accessed through the virtual shareholder meeting website at www.virtualshareholdermeeting.com/OMER2026. A general corporate overview and question-and-answer session will follow the business portion of the annual meeting.

As described in the company’s proxy statement, filed April 30, 2026, only shareholders of record as of the close of business on April 17, 2026 are entitled

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Mon, 15 Jun 2026 08:30:00 -0400

As described in the company’s proxy statement, filed April 30, 2026, only shareholders of record as of the close of business on April 17, 2026 are entitled

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Mon, 15 Jun 2026 08:30:00 -0400

As described in the company’s proxy statement, filed April 30, 2026, only shareholders of record as of the close of business on April 17, 2026 are entitled

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Mon, 15 Jun 2026 08:30:00 -0400

As described in the company’s proxy statement, filed April 30, 2026, only shareholders of record as of the close of business on April 17, 2026 are entitled

Increasing unusual put option volume: SPCE FITB OMER BIRK TRIP SATS PURR

Mon, 15 Jun 2026 06:24:36 -0400

Increasing unusual put option volume: SPCE FITB OMER BIRK TRIP SATS PURR

Increasing unusual put volume: OMER TRIP SPCE PURR BIRK XP

Fri, 12 Jun 2026 11:38:07 -0400

Increasing unusual put volume: OMER TRIP SPCE PURR BIRK XP

Increasing unusual call OMER TRIP SPCE PURR XP

Fri, 12 Jun 2026 11:25:05 -0400

Increasing unusual call OMER TRIP SPCE PURR XP

Omeros (OMER) Halted on Circuit Volatility, Down 22%

Fri, 12 Jun 2026 09:48:10 -0400

Omeros (NASDAQ: OMER) Halted on Circuit Volatility, Down 22%

H.C. Wainwright Reiterates Buy Rating on Omeros Corp. (OMER)

Wed, 10 Jun 2026 07:12:47 -0400

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating and $40.00 price target on Omeros Corp. (NASDAQ: OMER).

The analyst commented: "The data could come as early as around EHA 2026 (June 11–14), or potentially around ISTH 2026 (July 11–15), and OMER stock has weakened into the event despite what we view as a strong early U.S. launch for YARTEMLEA. In our view, the market is over-discounting the risk that positive ravulizumab data will meaningfully impair YARTEMLEA’s near-term commercial trajectory. A positive dataset could keep C5 inhibition in the treatment discussion and would likely improve reimbursement for ravulizumab if Ultomiris ultimately

Form 4 OMEROS CORP For: May 22 Filed by: Cable Thomas J.

Wed, 27 May 2026 18:21:00 -0400

si-local-file:///var/storage/secattach/20260527/26559407.html

Form 4 OMEROS CORP For: May 22 Filed by: Cable Thomas J.

Wed, 27 May 2026 18:21:00 -0400

si-local-file:///var/storage/secattach/20260527/26559407.html

Form 144 OMEROS CORP Filed by: Cable Thomas J.

Fri, 22 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260522/26542361.html

Form 144 OMEROS CORP Filed by: Cable Thomas J.

Fri, 22 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260522/26542361.html

Omeros (OMER) Misses Q1 EPS by 12c

Wed, 13 May 2026 16:19:40 -0400

Omeros (NASDAQ: OMER) reported Q1 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $9.89 million versus the consensus estimate of $40.15 million.

For earnings history and earnings-related data on Omeros (OMER) click here.

Omeros (OMER) Misses Q1 EPS by 12c

Wed, 13 May 2026 16:11:45 -0400

Omeros (NASDAQ: OMER) reported Q1 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $9.89 million versus the consensus estimate of $40.15 million.

For earnings history and earnings-related data on Omeros (OMER) click here.

Form 10-Q OMEROS CORP For: Mar 31

Wed, 13 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260513/26485988.html

Form 10-Q OMEROS CORP For: Mar 31

Wed, 13 May 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260513/26485988.html

Form 8-K OMEROS CORP For: May 13

Wed, 13 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260513/26485965.html

Form 8-K OMEROS CORP For: May 13

Wed, 13 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260513/26485965.html

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or

Omeros Corporation Reports First Quarter 2026 Financial Results

Wed, 13 May 2026 16:02:00 -0400

– Conference Call Today at 4:30 p.m. ET

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include:

First Quarter and Recent Highlights

In January 2026, we launched YARTEMLEA® in the U.S. market. During the quarter, gross product sales were $11.1 million and associated net sales, after deduction of wholesaler distribution fees and chargebacks, were $9.9 million.

Net income for the first quarter of 2026 was $56.1 million, or $0.78 per share, compared to a net loss of $33.5 million, or